The dual-function chemokine receptor CCR2 drives migration and chemokine scavenging through distinct mechanisms

被引:10
|
作者
Shroka, Thomas M. [1 ,2 ]
Kufareva, Irina [2 ]
Salanga, Catherina L. [2 ]
Handel, Tracy M. [2 ]
机构
[1] Univ Calif San Diego, Sch Med, Biomed Sci Program, La Jolla, CA 92093 USA
[2] Univ Calif San Diego, Skaggs Sch Pharm & Pharmaceut Sci, La Jolla, CA 92093 USA
关键词
BETA-ADRENERGIC-RECEPTOR; RECYCLING ENDOSOMES; GAMMA-SUBUNITS; PROTEIN; ARRESTIN; INTERNALIZATION; DESENSITIZATION; INFLAMMATION; IMMUNE; TRAFFICKING;
D O I
10.1126/scisignal.abo4314
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
C-C chemokine receptor 2 (CCR2) is a dual-function receptor. Similar to other G protein-coupled chemokine receptors, it promotes monocyte infiltration into tissues in response to the chemokine CCL2, and, like atypical chemokine receptors (ACKRs), it scavenges chemokine from the extracellular environment. CCR2 therefore me-diates CCL2-dependent signaling as a G protein-coupled receptor (GPCR) and also limits CCL2 signaling as a scavenger receptor. We investigated the mechanisms underlying CCR2 scavenging, including the involvement of intracellular proteins typically associated with GPCR signaling and internalization. Using CRISPR knockout cell lines, we showed that CCR2 scavenged by constitutively internalizing to remove CCL2 from the extracellular space and recycling back to the cell surface for further rounds of ligand sequestration. This process occurred independently of G proteins, GPCR kinases (GRKs), beta-arrestins, and clathrin, which is distinct from other "pro-fessional" chemokine scavenger receptors that couple to GRKs, beta-arrestins, or both. These findings set the stage for understanding the molecular regulators that determine CCR2 scavenging and may have implications for drug development targeting this therapeutically important receptor.
引用
收藏
页数:15
相关论文
共 50 条
  • [41] Investigating Chemokine Receptor CCR2 Dynamics and Druggability by Ensemble Based Approaches
    Taylor, Bryn C.
    Kufareva, Irina
    Handel, Tracy
    Amaro, Rommie E.
    BIOPHYSICAL JOURNAL, 2018, 114 (03) : 399A - 399A
  • [42] Expression of chemokine receptor CCR2 in rodent and old world monkey brain
    Smith, RE
    Kunkel, SL
    Meador-Woodruff, JH
    BIOLOGICAL PSYCHIATRY, 1999, 45 (08) : 87S - 87S
  • [43] Inducing receptor degradation as a novel approach to target CC chemokine receptor 2 (CCR2)
    Zacarias, Natalia Ortiz
    Broekhuis, Jeremy
    van der Es, Daan
    Heitman, Laura H.
    BRITISH JOURNAL OF PHARMACOLOGY, 2023, 180 : 657 - 658
  • [44] Discovery and Mapping of an Intracellular Antagonist Binding Site at the Chemokine Receptor CCR2
    Zweemer, Annelien J. M.
    Bunnik, Julia
    Veenhuizen, Margo
    Miraglia, Fabiana
    Lenselink, Eelke B.
    Vilums, Maris
    de Vries, Henk
    Gibert, Arthur
    Thiele, Stefanie
    Rosenkilde, Mette M.
    IJzerman, Adriaan P.
    Heitman, Laura H.
    MOLECULAR PHARMACOLOGY, 2014, 86 (04) : 358 - 368
  • [45] Isolation and Structures of Novel Fungal Metabolites as Chemokine Receptor (CCR2) Antagonists
    Kithsiri B Herath
    Hiranthi Jayasuriya
    John G Ondeyka
    Jon D Polishook
    Gerald F Bills
    Anne W Dombrowski
    Angeles Cabello
    Pasquale P Vicario
    Hans Zweerink
    Ziqiang Guan
    Sheo B Singh
    The Journal of Antibiotics, 2005, 58 : 686 - 694
  • [46] MONOCYTE/MACROPHAGE CHEMOKINE RECEPTOR CCR2 MEDIATES DIABETIC RENAL INJURY
    Awad, A. S.
    Gao, T.
    INFLAMMATION RESEARCH, 2011, 60 : 73 - 74
  • [47] Sensitive flow cytometric detection of the chemokine receptor CCR2 on mouse leukocytes
    Ford, L.
    Hansell, C.
    Nibbs, R.
    IMMUNOLOGY, 2010, 131 : 140 - 141
  • [48] Impaired neuropathic pain responses in mice lacking the chemokine receptor CCR2
    Abbadie, C
    Lindia, JA
    Cumiskey, AM
    Peterson, LB
    Mudgett, JS
    Bayne, EK
    DeMartino, JA
    MacIntyre, DE
    Forrest, MJ
    PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2003, 100 (13) : 7947 - 7952
  • [49] Rationale of using the dual chemokine receptor CCR2/CCR5 inhibitor cenicriviroc for the treatment of COVID-19
    Files, Daniel Clark
    Tacke, Frank
    O'Sullivan, Alexandra
    Dorr, Patrick
    Ferguson, William G.
    Powderly, William G.
    PLOS PATHOGENS, 2022, 18 (06)
  • [50] Overexpression of the chemokine receptor CCR2 in the breast epithelium is associated with progression of DCIS
    Mafuvadze, Benford
    Fang, Wei Bin
    Cheng, Nikki
    CANCER RESEARCH, 2015, 75